CD137 ligand signaling inhibited proliferation, induced cell cycle arrest and apoptosis and resulted in an increased secretion of IL-6 and IL-8 selectively in MM cell lines but not in non-MM B cell lymphoma cells. Here, CXCL8 is linked to B-cell non-Hodgkin lymphoma.